Table 3.
Target | Antibody format | Antibody origin | Application | References |
---|---|---|---|---|
TcdB | scFv | Human | ELISA | Deng et al. (2003) |
FliC, FliD | scFv | Human | ELISA, WB, in vitro assay | Shirvan and Aitken (2016) |
SLP | sdAb | Llama | ELISA, WB, in vitro assay | Kandalaft et al. (2015) |
TcdA | sdAb | Llama | ELISA, WB, in vitro neutralization | Hussack et al. (2011) |
TcdA, TcdB | sdAb, bispecific | Alpaca | ELISA, in vitro assay, in vivo protection | Yang et al. (2014) |
TcdB | scFv-Fc | Human | in vitro neutralization | Chung et al. (2018) |
Binary CDT toxin | sdAb, sdAb-Fc | Llama | ELISA, IF | Unger et al. (2015) |
TcdA, toxin A; TcdB, toxin B; SLP, surface-layer protein; scFv, single-chain fragment variable; sdAb, single-domain antibodies; Fc, fragment crystallizable region; ELISA, enzyme linked immunosorbent assays; WB, western blot; IF, immuno fluorescence microscopy.